Prev Arrow Stocks

Chemours Company (The) ($CC) Stock Forecast: Up 5.6% Today

Morpher AI identified a bullish signal. The stock price may continue to rise based on the momentum of the good news.

What is Chemours Company (The)?

Chemours Co (CC) saw a rise in its stock performance in the financial market today.

Why is Chemours Company (The) going up?

CC stock is up 5.6% on Jun 17, 2026 14:55

  • Despite a 3.4% decrease in CC's stock value, the general market sentiment stayed positive.
  • CC's stock is currently deemed overpriced by GuruFocus, with a trading value surpassing the inherent value estimate, hinting at potential risks for investors.
  • The company's profit margins play a key role in its GF Score of 66/100, yet its weak financial position and absence of internal transactions warrant attention.
  • A P/E ratio above the median at 16.6x suggests that investors might be paying a premium for the stock, potentially influencing today's positive market movement as traders showed optimism towards the company's future outlook.

CC Price Chart

CC Technical Analysis

CC News

The Chemours Co (CC) Stock Down 3.4% but Still Overvalued -- GF Score: 66/100

The Chemours Co (CC) saw its shares drop by 3.4% to $21.67, but the stock is still considered overvalued by GuruFocus, with its current price 9.2% above the intrinsic value estimate of $19.84. The company has a GF Score of 66/100, driven by its profitability but hindered by weak financial strength and lack of recent insider transactions, suggesting caution for potential investors. Its current P/E ratio of 16.6x is also significantly higher than its 5-year median.

https://www.gurufocus.com/news/8919681/the-chemours-co-cc-stock-down-34-but-still-overvalued-gf-score-66100

0 Missing News Article Image The Chemours Co (CC) Stock Down 3.4% but Still Overvalued -- GF Score: 66/100

Chemours Company (The) Price History

05.05.2026 - CC Stock was down 5.0%

  • Today's bearish movement in CC stock can be attributed to a combination of factors:
  • The appeals court overturning the ruling to stop Chemours from polluting the Ohio River may have raised concerns among investors about the company's environmental practices and potential regulatory challenges.
  • The company's recent financial performance, with a net loss in Q1 2026 and underperforming earnings compared to estimates, likely contributed to the negative sentiment and selling pressure on the stock.
  • Despite honoring distinguished researchers with a scientific excellence award, the positive news may have been overshadowed by the broader concerns regarding compliance issues and financial outlook.
  • The AI-generated analysis highlighting positive sentiment and potential gains may not have been sufficient to offset the overall negative market sentiment and uncertainties surrounding Chemours' operations and future prospects.

07.04.2026 - CC Stock was down 5.2%

  • Chemours (CC) recorded a Q1 loss of US$29 million, raising concerns about its profitability and influencing the bearish market trend.
  • Despite displaying some positive operational advancements, the stock faced a 13% decline due to the market's negative response to adjusted earnings guidance and heightened financial commitments.
  • The company's declaration of a quarterly cash dividend potentially offered some stability, but the focus on margins, revenue growth, and financial pressures contributed to the prevailing bearish outlook.
  • Observers are particularly attentive to Chemours' pricing strategies, operational efficiencies, and ability to navigate geopolitical challenges as they evaluate its future trajectory and market sentiment.

02.05.2026 - CC Stock was up 7.2%

  • Today's bullish movement in CC stock is possibly linked to a new partnership with the Wood County Technical Center. This collaboration not only boosts the company's reputation but also signals a dedication to supporting the manufacturing workforce, which could be seen positively by investors.
  • Initially, some market uncertainty may have arisen due to an amicus brief filed in the antitrust lawsuit against Chemours by attorneys general. However, the subsequent dismissal of the lawsuit, along with an appeal and a focus on thoroughly assessing monopoly claims, may have reassured investors about the company's legal position and future opportunities in the refrigerant market.
  • In summary, the positive partnership news and potential regulatory clarity post-lawsuit developments likely contributed to the bullish movement in CC stock today. These factors could be interpreted by investors as signs of growth and reliability for the company going forward.

11.05.2026 - CC Stock was up 5.0%

  • Recent market activity saw a notable upward trend in Chemours stock (CC) following a period of declines, possibly attributed to the emphasis on scientific advancement and talent retention within the company.
  • The introduction of the "Catalyst for Scientific Excellence Award" signals a commitment to nurturing a robust research environment, paving the way for potential future innovations and product advancements that could positively influence long-term investor sentiments.
  • Resolving a pollution injunction and responding to antitrust allegations likely provided investors with a sense of assurance and adherence, contributing to the bullish market movement.
  • Despite lingering financial uncertainties, Chemours' proactive approach towards promoting its research culture and addressing legal matters may have bolstered investor confidence in the company's growth prospects over the long run.

21.04.2026 - CC Stock was down 5.2%

  • Chemours (CC) stock saw a significant decline of 8.4% today.
  • A Q1 2026 net loss of US$29 million was reported by the company, possibly contributing to the negative market reaction.
  • Despite unveiling new guidance for a profitable trajectory in 2026, concerns regarding PFAS litigation and the necessity for successful execution of the guidance appear to have overshadowed the positive outlook.
  • Ongoing legal disputes with the North Carolina Attorney General concerning environmental issues and the uncertainty surrounding the lawsuit's resolution may also be impacting investor confidence in Chemours.

19.04.2026 - CC Stock was down 7.3%

  • Chemours reported a Q1 net loss but issued new guidance projecting a path to profitability for the full year, leading to investor concerns and contributing to the bearish movement.
  • Despite receiving awards for energy efficiency and sustainable manufacturing initiatives, persistent concerns about PFAS litigation and the need for strong execution on new guidance continue to weigh on investor sentiment.
  • The company's CFO discussed cost reduction strategies and forecasted adjusted EBITDA, but uncertainties around PFAS-related liabilities and tariffs impact on business operations may have added to the downward pressure on the stock.
  • The industry study highlighting a path to cut automotive refrigerant emissions in Europe could have a positive long-term impact on Chemours' sustainability efforts, but the immediate market reaction seems to have been influenced more by the near-term financial outlook and litigation concerns.

15.04.2026 - CC Stock was down 5.2%

  • The bearish movement in Chemours Corporation's stock (CC) today could be attributed to several factors:
  • Despite receiving recognition for its energy efficiency initiatives and sustainable manufacturing practices, investors may have been looking for more immediate financial gains rather than long-term sustainability efforts.
  • Discussions of cost reductions and adjusted EBITDA forecasts might have raised concerns about potential challenges in achieving these targets, leading to a lack of confidence among investors.
  • The actions to cut automotive refrigerant emissions in Europe, while positive for the environment, may have raised questions about the company's future revenue streams if regulatory changes impact its products in the automotive sector.
  • The information about the number of shareholders could indicate a lack of significant new investors or institutional interest in the company, potentially signaling a lack of market confidence in CC's growth prospects.

17.05.2026 - CC Stock was up 5.6%

  • Despite a 3.4% decrease in CC's stock value, the general market sentiment stayed positive.
  • CC's stock is currently deemed overpriced by GuruFocus, with a trading value surpassing the inherent value estimate, hinting at potential risks for investors.
  • The company's profit margins play a key role in its GF Score of 66/100, yet its weak financial position and absence of internal transactions warrant attention.
  • A P/E ratio above the median at 16.6x suggests that investors might be paying a premium for the stock, potentially influencing today's positive market movement as traders showed optimism towards the company's future outlook.

06.04.2026 - CC Stock was down 16.0%

  • Today, Chemours experienced a decline in its stock price, possibly due to the company's failure to meet revenue expectations in Q1, reporting $1.38 billion instead of the anticipated $1.40 billion.
  • While announcing a new dividend and achieving a 52-week high were positive developments, the slight revenue miss may have raised uncertainties among investors about the company's future growth.
  • The use of AI models indicating increased downside risk at current levels might have also influenced bearish sentiment, leading some investors to cash in profits or adjust their positions cautiously.
  • The market's response appears to combine profit-taking following recent strong performance and some ambiguity surrounding Chemours' revenue outlook in the short term.

04.05.2026 - CC Stock was down 6.8%

  • The court ruling concerning water pollution raised concerns among investors, potentially signaling regulatory and environmental challenges for Chemours, leading to a decline in the stock price.
  • Despite positive sentiments from AI analysis and recognition for scientific achievements, legal troubles and regulatory issues faced by Chemours overshadowed the company’s outlook, affecting investor confidence.
  • State attorneys general involvement in an antitrust lawsuit concerning HVAC refrigerants added further uncertainty to Chemours' market standing, potentially influencing the bearish stock performance.
  • Legal battles, regulatory uncertainties, and market competition in refrigerants collectively contributed to the downward movement in Chemours' stock price.

05.04.2026 - CC Stock was up 5.5%

  • CC stock hit a new 52-week high of $27.53, marking a significant 130% year-to-date increase, driven by strong investor confidence and strategic growth measures.
  • The successful $700 million debt issuance to retire existing notes and positive analyst projections regarding enhanced profitability and higher titanium dioxide EBITDA margins have further propelled the optimistic sentiment.
  • Despite concerns raised about potential overvaluation, positive market sentiment, approval of equity plans by shareholders, and the appointment of an independent auditor have all played a role in the stock's upward trend.
  • Strategic decisions, such as the endorsement of the 2026 Equity and Incentive Plan and favorable analyst reviews, are likely factors boosting investor confidence and contributing to the positive momentum in CC stock.

11.04.2026 - CC Stock was up 5.0%

  • The positive sentiment surrounding CC stock's uptrend might be linked to the completion of a Euro-denominated term loan repricing, hinting at potential cost savings for the company.
  • Notable insider stock grants were awarded to directors Courtney Mather, Mary B. Cranston, and Erin N. Kane, potentially boosting investor confidence in the company's growth trajectory.
  • The equity awards given to directors in a non-cash form indicate alignment with shareholders' interests, which could enhance investor trust in the stock.
  • In summary, a mix of favorable financial updates and insider activities likely fueled the bullish movement of CC stock during the day.
i
Disclaimer
Morpher is not liable for the content of the AI investment insights. Like most GPT-powered tools, these summaries may contain AI hallucinations and inaccurate information. Morpher is not presenting you with any investment advice. All investments involve risk, and the past performance of a security, industry, sector, market, or financial product does not guarantee future results or returns. Investors are fully responsible for any investment decisions they make. Such decisions should be based solely on an evaluation of their financial circumstances, investment objectives, risk tolerance, and liquidity needs. These summaries do not constitute investment advice.